Lapcid-KId Tablet MD contains Lansoprazole 15 mg, a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal ulcers, and gastric ulcers. Lansoprazole also plays a significant role in the eradication of Helicobacter pylori infection when used in combination with appropriate antibiotics. The medication provides symptomatic relief from heartburn, acid regurgitation, and other related upper gastrointestinal symptoms by promoting mucosal healing and reducing acid-mediated tissue damage. Lapcid-KId Tablet MD is generally well tolerated, with common adverse effects including headache, diarrhea, abdominal pain, and nausea. It should be used with caution in patients with hepatic impairment and is contraindicated in individuals with known hypersensitivity to lansoprazole or other PPIs. The recommended dosage is one tablet daily, preferably taken before meals to optimize acid suppression. Long-term use requires periodic evaluation due to potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Patients should consult healthcare providers before initiating therapy to ensure appropriate use and monitoring.